We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.88 | -1.22% | 71.33 | 72.56 | 70.97 | 72.47 | 3,033,493 | 17:26:16 |
From May 2021 to May 2024
By Matt Grossman
Boston Scientific Corp. on Tuesday returned to a profit in the second quarter, as sales recovered amid higher healthcare demand as the coronavirus pandemic eased.
The Marlborough, Mass.-based medical-devices maker logged earnings of 12 cents a share, compared with a loss of 11 cents a share a year earlier. Total net income was $186 million, compared with a net loss of $147 million.
Stripping out one-time items, the company's adjusted earnings were 40 cents a share. Analysts polled by FactSet were forecasting adjusted earnings of 37 cents a share.
Sales rose to $3.08 billion from $2 billion a year earlier, the company said. Analysts had been anticipating sales of $2.94 billion.
Medical-surgical sales rose 65% to $948 million. Rhythm and neuro sales were up 65% at $866 million. Cardiovascular sales improved by 51% to $1.26 billion, the company said.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
July 27, 2021 07:02 ET (11:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
